nodes	percent_of_prediction	percent_of_DWPC	metapath
Pseudoephedrine—IL2—neck—thyroid cancer	0.0441	0.186	CbGeAlD
Pseudoephedrine—NFATC1—thyroid gland—thyroid cancer	0.023	0.0966	CbGeAlD
Pseudoephedrine—IL2—thyroid gland—thyroid cancer	0.021	0.0884	CbGeAlD
Pseudoephedrine—NFATC1—head—thyroid cancer	0.0204	0.0857	CbGeAlD
Pseudoephedrine—IL2—head—thyroid cancer	0.0186	0.0784	CbGeAlD
Pseudoephedrine—NFATC1—lymph node—thyroid cancer	0.0143	0.06	CbGeAlD
Pseudoephedrine—TNF—lymph node—thyroid cancer	0.0136	0.0573	CbGeAlD
Pseudoephedrine—IL2—lymph node—thyroid cancer	0.013	0.0549	CbGeAlD
Pseudoephedrine—MAOA—neck—thyroid cancer	0.00867	0.0365	CbGeAlD
Pseudoephedrine—Cerebral haemorrhage—Sorafenib—thyroid cancer	0.00837	0.0674	CcSEcCtD
Pseudoephedrine—MAOA—saliva-secreting gland—thyroid cancer	0.00676	0.0284	CbGeAlD
Pseudoephedrine—MAOA—trachea—thyroid cancer	0.00521	0.0219	CbGeAlD
Pseudoephedrine—SLC6A3—head—thyroid cancer	0.00492	0.0207	CbGeAlD
Pseudoephedrine—ADRB1—head—thyroid cancer	0.00467	0.0196	CbGeAlD
Pseudoephedrine—Blood pressure increased—Sorafenib—thyroid cancer	0.00464	0.0373	CcSEcCtD
Pseudoephedrine—SLC6A4—head—thyroid cancer	0.00451	0.019	CbGeAlD
Pseudoephedrine—MAOA—thyroid gland—thyroid cancer	0.00412	0.0174	CbGeAlD
Pseudoephedrine—Dysuria—Vandetanib—thyroid cancer	0.00403	0.0325	CcSEcCtD
Pseudoephedrine—ADRA2A—trachea—thyroid cancer	0.004	0.0168	CbGeAlD
Pseudoephedrine—SLC6A2—head—thyroid cancer	0.00397	0.0167	CbGeAlD
Pseudoephedrine—ADRA1A—head—thyroid cancer	0.00369	0.0155	CbGeAlD
Pseudoephedrine—MAOA—head—thyroid cancer	0.00366	0.0154	CbGeAlD
Pseudoephedrine—Bradycardia—Vandetanib—thyroid cancer	0.00351	0.0283	CcSEcCtD
Pseudoephedrine—ADRA2A—thyroid gland—thyroid cancer	0.00316	0.0133	CbGeAlD
Pseudoephedrine—Arrhythmia—Vandetanib—thyroid cancer	0.00308	0.0248	CcSEcCtD
Pseudoephedrine—Muscle spasms—Vandetanib—thyroid cancer	0.00289	0.0233	CcSEcCtD
Pseudoephedrine—Tremor—Vandetanib—thyroid cancer	0.00281	0.0227	CcSEcCtD
Pseudoephedrine—ADRA2A—head—thyroid cancer	0.00281	0.0118	CbGeAlD
Pseudoephedrine—SLC6A2—lymph node—thyroid cancer	0.00278	0.0117	CbGeAlD
Pseudoephedrine—Hypertension—Vandetanib—thyroid cancer	0.00259	0.0209	CcSEcCtD
Pseudoephedrine—MAOA—lymph node—thyroid cancer	0.00256	0.0108	CbGeAlD
Pseudoephedrine—Chest pain—Vandetanib—thyroid cancer	0.00256	0.0206	CcSEcCtD
Pseudoephedrine—Anxiety—Vandetanib—thyroid cancer	0.00255	0.0205	CcSEcCtD
Pseudoephedrine—Insomnia—Vandetanib—thyroid cancer	0.00222	0.0179	CcSEcCtD
Pseudoephedrine—Dyspnoea—Vandetanib—thyroid cancer	0.00219	0.0176	CcSEcCtD
Pseudoephedrine—CYP2D6—head—thyroid cancer	0.00217	0.00915	CbGeAlD
Pseudoephedrine—Dyspepsia—Vandetanib—thyroid cancer	0.00216	0.0174	CcSEcCtD
Pseudoephedrine—Decreased appetite—Vandetanib—thyroid cancer	0.00213	0.0172	CcSEcCtD
Pseudoephedrine—Pain—Vandetanib—thyroid cancer	0.0021	0.0169	CcSEcCtD
Pseudoephedrine—Arrhythmia—Sorafenib—thyroid cancer	0.00208	0.0168	CcSEcCtD
Pseudoephedrine—Delirium—Epirubicin—thyroid cancer	0.00199	0.016	CcSEcCtD
Pseudoephedrine—ADRA2A—lymph node—thyroid cancer	0.00197	0.00827	CbGeAlD
Pseudoephedrine—Muscle spasms—Sorafenib—thyroid cancer	0.00195	0.0157	CcSEcCtD
Pseudoephedrine—Body temperature increased—Vandetanib—thyroid cancer	0.00194	0.0156	CcSEcCtD
Pseudoephedrine—Delirium—Doxorubicin—thyroid cancer	0.00184	0.0148	CcSEcCtD
Pseudoephedrine—Asthenia—Vandetanib—thyroid cancer	0.00176	0.0142	CcSEcCtD
Pseudoephedrine—Hypertension—Sorafenib—thyroid cancer	0.00175	0.0141	CcSEcCtD
Pseudoephedrine—Dizziness—Vandetanib—thyroid cancer	0.00162	0.0131	CcSEcCtD
Pseudoephedrine—Anorexia—Sorafenib—thyroid cancer	0.00158	0.0127	CcSEcCtD
Pseudoephedrine—Vomiting—Vandetanib—thyroid cancer	0.00156	0.0126	CcSEcCtD
Pseudoephedrine—Rash—Vandetanib—thyroid cancer	0.00155	0.0125	CcSEcCtD
Pseudoephedrine—Dermatitis—Vandetanib—thyroid cancer	0.00154	0.0124	CcSEcCtD
Pseudoephedrine—Headache—Vandetanib—thyroid cancer	0.00154	0.0124	CcSEcCtD
Pseudoephedrine—Dyspnoea—Sorafenib—thyroid cancer	0.00147	0.0119	CcSEcCtD
Pseudoephedrine—Nausea—Vandetanib—thyroid cancer	0.00146	0.0117	CcSEcCtD
Pseudoephedrine—Dyspepsia—Sorafenib—thyroid cancer	0.00146	0.0117	CcSEcCtD
Pseudoephedrine—Decreased appetite—Sorafenib—thyroid cancer	0.00144	0.0116	CcSEcCtD
Pseudoephedrine—Pain—Sorafenib—thyroid cancer	0.00141	0.0114	CcSEcCtD
Pseudoephedrine—Body temperature increased—Sorafenib—thyroid cancer	0.00131	0.0105	CcSEcCtD
Pseudoephedrine—Asthenia—Sorafenib—thyroid cancer	0.00119	0.00956	CcSEcCtD
Pseudoephedrine—Dizziness—Sorafenib—thyroid cancer	0.00109	0.00881	CcSEcCtD
Pseudoephedrine—Vomiting—Sorafenib—thyroid cancer	0.00105	0.00847	CcSEcCtD
Pseudoephedrine—Angina pectoris—Epirubicin—thyroid cancer	0.00105	0.00843	CcSEcCtD
Pseudoephedrine—Rash—Sorafenib—thyroid cancer	0.00104	0.0084	CcSEcCtD
Pseudoephedrine—Dermatitis—Sorafenib—thyroid cancer	0.00104	0.00839	CcSEcCtD
Pseudoephedrine—Headache—Sorafenib—thyroid cancer	0.00104	0.00835	CcSEcCtD
Pseudoephedrine—Dysuria—Epirubicin—thyroid cancer	0.001	0.0081	CcSEcCtD
Pseudoephedrine—Nausea—Sorafenib—thyroid cancer	0.000982	0.00791	CcSEcCtD
Pseudoephedrine—Angina pectoris—Doxorubicin—thyroid cancer	0.000969	0.0078	CcSEcCtD
Pseudoephedrine—Dysuria—Doxorubicin—thyroid cancer	0.00093	0.00749	CcSEcCtD
Pseudoephedrine—Sweating—Epirubicin—thyroid cancer	0.000919	0.0074	CcSEcCtD
Pseudoephedrine—Bradycardia—Epirubicin—thyroid cancer	0.000876	0.00705	CcSEcCtD
Pseudoephedrine—Sweating—Doxorubicin—thyroid cancer	0.00085	0.00685	CcSEcCtD
Pseudoephedrine—Bradycardia—Doxorubicin—thyroid cancer	0.00081	0.00653	CcSEcCtD
Pseudoephedrine—Arrhythmia—Epirubicin—thyroid cancer	0.000768	0.00619	CcSEcCtD
Pseudoephedrine—Tension—Epirubicin—thyroid cancer	0.000735	0.00592	CcSEcCtD
Pseudoephedrine—Nervousness—Epirubicin—thyroid cancer	0.000727	0.00586	CcSEcCtD
Pseudoephedrine—Muscle spasms—Epirubicin—thyroid cancer	0.00072	0.0058	CcSEcCtD
Pseudoephedrine—Arrhythmia—Doxorubicin—thyroid cancer	0.000711	0.00573	CcSEcCtD
Pseudoephedrine—Agitation—Epirubicin—thyroid cancer	0.000688	0.00554	CcSEcCtD
Pseudoephedrine—Tension—Doxorubicin—thyroid cancer	0.00068	0.00548	CcSEcCtD
Pseudoephedrine—Nervousness—Doxorubicin—thyroid cancer	0.000673	0.00542	CcSEcCtD
Pseudoephedrine—Vertigo—Epirubicin—thyroid cancer	0.000673	0.00542	CcSEcCtD
Pseudoephedrine—Muscle spasms—Doxorubicin—thyroid cancer	0.000666	0.00537	CcSEcCtD
Pseudoephedrine—Palpitations—Epirubicin—thyroid cancer	0.000662	0.00533	CcSEcCtD
Pseudoephedrine—Hypertension—Epirubicin—thyroid cancer	0.000647	0.00521	CcSEcCtD
Pseudoephedrine—Chest pain—Epirubicin—thyroid cancer	0.000638	0.00514	CcSEcCtD
Pseudoephedrine—Agitation—Doxorubicin—thyroid cancer	0.000637	0.00513	CcSEcCtD
Pseudoephedrine—Anxiety—Epirubicin—thyroid cancer	0.000635	0.00512	CcSEcCtD
Pseudoephedrine—Vertigo—Doxorubicin—thyroid cancer	0.000623	0.00501	CcSEcCtD
Pseudoephedrine—Confusional state—Epirubicin—thyroid cancer	0.000616	0.00496	CcSEcCtD
Pseudoephedrine—Palpitations—Doxorubicin—thyroid cancer	0.000612	0.00493	CcSEcCtD
Pseudoephedrine—Hypertension—Doxorubicin—thyroid cancer	0.000598	0.00482	CcSEcCtD
Pseudoephedrine—Tachycardia—Epirubicin—thyroid cancer	0.000596	0.00481	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Epirubicin—thyroid cancer	0.000591	0.00476	CcSEcCtD
Pseudoephedrine—Chest pain—Doxorubicin—thyroid cancer	0.00059	0.00475	CcSEcCtD
Pseudoephedrine—Anxiety—Doxorubicin—thyroid cancer	0.000588	0.00474	CcSEcCtD
Pseudoephedrine—Anorexia—Epirubicin—thyroid cancer	0.000583	0.00469	CcSEcCtD
Pseudoephedrine—Confusional state—Doxorubicin—thyroid cancer	0.00057	0.00459	CcSEcCtD
Pseudoephedrine—Insomnia—Epirubicin—thyroid cancer	0.000553	0.00445	CcSEcCtD
Pseudoephedrine—Tachycardia—Doxorubicin—thyroid cancer	0.000552	0.00445	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000547	0.0044	CcSEcCtD
Pseudoephedrine—Dyspnoea—Epirubicin—thyroid cancer	0.000545	0.00439	CcSEcCtD
Pseudoephedrine—Anorexia—Doxorubicin—thyroid cancer	0.000539	0.00434	CcSEcCtD
Pseudoephedrine—Dyspepsia—Epirubicin—thyroid cancer	0.000538	0.00433	CcSEcCtD
Pseudoephedrine—Decreased appetite—Epirubicin—thyroid cancer	0.000531	0.00428	CcSEcCtD
Pseudoephedrine—Pain—Epirubicin—thyroid cancer	0.000523	0.00421	CcSEcCtD
Pseudoephedrine—Insomnia—Doxorubicin—thyroid cancer	0.000511	0.00412	CcSEcCtD
Pseudoephedrine—Dyspnoea—Doxorubicin—thyroid cancer	0.000504	0.00406	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Epirubicin—thyroid cancer	0.000504	0.00406	CcSEcCtD
Pseudoephedrine—Dyspepsia—Doxorubicin—thyroid cancer	0.000498	0.00401	CcSEcCtD
Pseudoephedrine—Decreased appetite—Doxorubicin—thyroid cancer	0.000492	0.00396	CcSEcCtD
Pseudoephedrine—Pain—Doxorubicin—thyroid cancer	0.000484	0.0039	CcSEcCtD
Pseudoephedrine—Body temperature increased—Epirubicin—thyroid cancer	0.000483	0.00389	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Doxorubicin—thyroid cancer	0.000466	0.00375	CcSEcCtD
Pseudoephedrine—Body temperature increased—Doxorubicin—thyroid cancer	0.000447	0.0036	CcSEcCtD
Pseudoephedrine—Asthenia—Epirubicin—thyroid cancer	0.000438	0.00353	CcSEcCtD
Pseudoephedrine—Asthenia—Doxorubicin—thyroid cancer	0.000406	0.00327	CcSEcCtD
Pseudoephedrine—Dizziness—Epirubicin—thyroid cancer	0.000404	0.00326	CcSEcCtD
Pseudoephedrine—Vomiting—Epirubicin—thyroid cancer	0.000389	0.00313	CcSEcCtD
Pseudoephedrine—Rash—Epirubicin—thyroid cancer	0.000385	0.0031	CcSEcCtD
Pseudoephedrine—Dermatitis—Epirubicin—thyroid cancer	0.000385	0.0031	CcSEcCtD
Pseudoephedrine—Headache—Epirubicin—thyroid cancer	0.000383	0.00308	CcSEcCtD
Pseudoephedrine—Dizziness—Doxorubicin—thyroid cancer	0.000374	0.00301	CcSEcCtD
Pseudoephedrine—TNF—Toll-like Receptor Signaling Pathway—AKT1—thyroid cancer	0.000365	0.000571	CbGpPWpGaD
Pseudoephedrine—Nausea—Epirubicin—thyroid cancer	0.000363	0.00292	CcSEcCtD
Pseudoephedrine—IL2—Hemostasis—KRAS—thyroid cancer	0.000363	0.000568	CbGpPWpGaD
Pseudoephedrine—Vomiting—Doxorubicin—thyroid cancer	0.00036	0.0029	CcSEcCtD
Pseudoephedrine—ADRA2A—Metabolism—CHST14—thyroid cancer	0.000358	0.000561	CbGpPWpGaD
Pseudoephedrine—Rash—Doxorubicin—thyroid cancer	0.000357	0.00287	CcSEcCtD
Pseudoephedrine—Dermatitis—Doxorubicin—thyroid cancer	0.000356	0.00287	CcSEcCtD
Pseudoephedrine—ADRA2A—GPCR ligand binding—SST—thyroid cancer	0.000356	0.000557	CbGpPWpGaD
Pseudoephedrine—Headache—Doxorubicin—thyroid cancer	0.000354	0.00285	CcSEcCtD
Pseudoephedrine—SLC6A3—Neuronal System—BRAF—thyroid cancer	0.000354	0.000555	CbGpPWpGaD
Pseudoephedrine—SLC6A2—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.00035	0.000548	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—TSHR—thyroid cancer	0.000344	0.000538	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—CALCA—thyroid cancer	0.000342	0.000536	CbGpPWpGaD
Pseudoephedrine—ADRA1A—AMPK Signaling—AKT1—thyroid cancer	0.00034	0.000533	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—TERT—thyroid cancer	0.000339	0.000532	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—TSHR—thyroid cancer	0.000336	0.000527	CbGpPWpGaD
Pseudoephedrine—Nausea—Doxorubicin—thyroid cancer	0.000336	0.00271	CcSEcCtD
Pseudoephedrine—NFATC1—Innate Immune System—HRAS—thyroid cancer	0.000328	0.000514	CbGpPWpGaD
Pseudoephedrine—TNF—MAPK Signaling Pathway—KRAS—thyroid cancer	0.000326	0.000511	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—HIF1A—thyroid cancer	0.000324	0.000508	CbGpPWpGaD
Pseudoephedrine—IL2—Hemostasis—TP53—thyroid cancer	0.000322	0.000505	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CALCB—thyroid cancer	0.000322	0.000505	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—NRG1—thyroid cancer	0.00032	0.000501	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—TSHR—thyroid cancer	0.000312	0.000489	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—PTGS2—thyroid cancer	0.00031	0.000486	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.00031	0.000485	CbGpPWpGaD
Pseudoephedrine—TNF—Apoptosis—TP53—thyroid cancer	0.000309	0.000484	CbGpPWpGaD
Pseudoephedrine—IL2—Hemostasis—HRAS—thyroid cancer	0.000308	0.000483	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—PRKAR1A—thyroid cancer	0.000307	0.000481	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TRIM33—thyroid cancer	0.000305	0.000479	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—TSHR—thyroid cancer	0.000305	0.000478	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—PRKAR1A—thyroid cancer	0.0003	0.000471	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CALCB—thyroid cancer	0.000299	0.000469	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	0.000294	0.000461	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—PTEN—thyroid cancer	0.000293	0.000459	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—MINPP1—thyroid cancer	0.000292	0.000457	CbGpPWpGaD
Pseudoephedrine—SLC6A4—Circadian rythm related genes—TP53—thyroid cancer	0.000291	0.000455	CbGpPWpGaD
Pseudoephedrine—TNF—MAPK Signaling Pathway—TP53—thyroid cancer	0.00029	0.000454	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—AKT1—thyroid cancer	0.00029	0.000454	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—HPGD—thyroid cancer	0.000289	0.000452	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—TERT—thyroid cancer	0.000287	0.00045	CbGpPWpGaD
Pseudoephedrine—TNF—Regulation of toll-like receptor signaling pathway—AKT1—thyroid cancer	0.000285	0.000446	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TRIM33—thyroid cancer	0.000284	0.000445	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—TSHR—thyroid cancer	0.000278	0.000436	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—HIF1A—thyroid cancer	0.000274	0.00043	CbGpPWpGaD
Pseudoephedrine—IL2—Hemostasis—AKT1—thyroid cancer	0.000272	0.000426	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—PTEN—thyroid cancer	0.00027	0.000423	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—BRAF—thyroid cancer	0.000269	0.000421	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—SST—thyroid cancer	0.000267	0.000419	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—IFNA2—thyroid cancer	0.000266	0.000417	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—PTCH1—thyroid cancer	0.000265	0.000416	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—SST—thyroid cancer	0.000261	0.00041	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	0.000261	0.00041	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—NRAS—thyroid cancer	0.000261	0.000409	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—PPARG—thyroid cancer	0.000261	0.000409	CbGpPWpGaD
Pseudoephedrine—TNF—Apoptosis—AKT1—thyroid cancer	0.000261	0.000409	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—PTCH1—thyroid cancer	0.00026	0.000407	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—TSHR—thyroid cancer	0.000258	0.000405	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—CALCA—thyroid cancer	0.000257	0.000403	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—TSHR—thyroid cancer	0.000253	0.000396	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TCF7L1—thyroid cancer	0.000252	0.000395	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—CALCA—thyroid cancer	0.000252	0.000394	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—PRKAR1A—thyroid cancer	0.000248	0.000389	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—NDUFA13—thyroid cancer	0.000248	0.000389	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—TPR—thyroid cancer	0.000248	0.000389	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—PTEN—thyroid cancer	0.000248	0.000388	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TCF7L1—thyroid cancer	0.000246	0.000386	CbGpPWpGaD
Pseudoephedrine—TNF—MAPK Signaling Pathway—AKT1—thyroid cancer	0.000245	0.000383	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—PRKAR1A—thyroid cancer	0.000244	0.000382	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—SST—thyroid cancer	0.000243	0.00038	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—NRAS—thyroid cancer	0.000242	0.000379	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—NRAS—thyroid cancer	0.000241	0.000378	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—SST—thyroid cancer	0.000237	0.000372	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—TSHR—thyroid cancer	0.000235	0.000368	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—CALCA—thyroid cancer	0.000234	0.000366	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CHST14—thyroid cancer	0.000233	0.000366	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—PRKAR1A—thyroid cancer	0.000231	0.000362	CbGpPWpGaD
Pseudoephedrine—MAOA—Transmission across Chemical Synapses—HRAS—thyroid cancer	0.000229	0.000358	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—CALCA—thyroid cancer	0.000229	0.000358	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—BRAF—thyroid cancer	0.000227	0.000356	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—KRAS—thyroid cancer	0.000225	0.000352	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—NRAS—thyroid cancer	0.000221	0.000346	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	0.000221	0.000346	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—SST—thyroid cancer	0.000216	0.000339	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—PTCH1—thyroid cancer	0.000215	0.000336	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Transmission across Chemical Synapses—HRAS—thyroid cancer	0.000212	0.000333	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—thyroid cancer	0.000212	0.000332	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—CDK1—thyroid cancer	0.000211	0.000331	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—CALCA—thyroid cancer	0.000208	0.000326	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—KRAS—thyroid cancer	0.000208	0.000326	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—KRAS—thyroid cancer	0.000208	0.000325	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—CDK1—thyroid cancer	0.000207	0.000324	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TCF7L1—thyroid cancer	0.000204	0.000319	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—SST—thyroid cancer	0.000201	0.000315	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—PTCH1—thyroid cancer	0.000199	0.000313	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—SST—thyroid cancer	0.000196	0.000308	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—CCND1—thyroid cancer	0.000196	0.000307	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—CALCA—thyroid cancer	0.000193	0.000303	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—HRAS—thyroid cancer	0.000191	0.000299	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—KRAS—thyroid cancer	0.00019	0.000298	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TCF7L1—thyroid cancer	0.000189	0.000297	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—PTEN—thyroid cancer	0.000189	0.000297	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—CALCA—thyroid cancer	0.000189	0.000296	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—HPGD—thyroid cancer	0.000188	0.000295	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—SLC5A5—thyroid cancer	0.000186	0.000291	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TSHR—thyroid cancer	0.000184	0.000289	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—thyroid cancer	0.000183	0.000286	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—SST—thyroid cancer	0.000182	0.000286	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—PRKAR1A—thyroid cancer	0.000181	0.000284	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TSHR—thyroid cancer	0.00018	0.000283	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—PRKAR1A—thyroid cancer	0.000177	0.000278	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—HRAS—thyroid cancer	0.000177	0.000277	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—HRAS—thyroid cancer	0.000176	0.000276	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—CALCA—thyroid cancer	0.000176	0.000275	CbGpPWpGaD
Pseudoephedrine—MAOA—Neuronal System—HRAS—thyroid cancer	0.000175	0.000274	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—MEN1—thyroid cancer	0.000173	0.000272	CbGpPWpGaD
Pseudoephedrine—IL2—GPCR downstream signaling—AKT1—thyroid cancer	0.000172	0.000269	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—CDK1—thyroid cancer	0.000171	0.000268	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—MEN1—thyroid cancer	0.00017	0.000266	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—NRAS—thyroid cancer	0.000169	0.000265	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—AKT1—thyroid cancer	0.000169	0.000264	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—CCND1—thyroid cancer	0.000166	0.00026	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—TPR—thyroid cancer	0.000166	0.00026	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PRKAR1A—thyroid cancer	0.000163	0.000256	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Neuronal System—HRAS—thyroid cancer	0.000163	0.000255	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—HRAS—thyroid cancer	0.000162	0.000253	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—PTEN—thyroid cancer	0.00016	0.000251	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—NRAS—thyroid cancer	0.00016	0.00025	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—CDK1—thyroid cancer	0.000159	0.000249	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—PTCH1—thyroid cancer	0.000157	0.000246	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—AKT1—thyroid cancer	0.000156	0.000245	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—RXRA—thyroid cancer	0.000156	0.000244	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—AKT1—thyroid cancer	0.000156	0.000244	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—thyroid cancer	0.000155	0.000243	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—PTCH1—thyroid cancer	0.000153	0.00024	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TSHR—thyroid cancer	0.000149	0.000234	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PRKAR1A—thyroid cancer	0.000147	0.00023	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—KRAS—thyroid cancer	0.000145	0.000228	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—SST—thyroid cancer	0.000143	0.000225	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—NRAS—thyroid cancer	0.000143	0.000224	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—AKT1—thyroid cancer	0.000143	0.000224	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—SST—thyroid cancer	0.00014	0.00022	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—MEN1—thyroid cancer	0.00014	0.00022	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TSHR—thyroid cancer	0.000139	0.000217	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CALCA—thyroid cancer	0.000138	0.000216	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—KRAS—thyroid cancer	0.000138	0.000215	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PRKAR1A—thyroid cancer	0.000136	0.000214	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CALCA—thyroid cancer	0.000135	0.000212	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—MEN1—thyroid cancer	0.00013	0.000204	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—TP53—thyroid cancer	0.000129	0.000202	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PTCH1—thyroid cancer	0.000127	0.000199	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CDK1—thyroid cancer	0.000125	0.000196	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	0.000125	0.000195	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—SLC5A5—thyroid cancer	0.000124	0.000194	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—HRAS—thyroid cancer	0.000124	0.000194	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—KRAS—thyroid cancer	0.000123	0.000193	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CDK1—thyroid cancer	0.000122	0.000191	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PTCH1—thyroid cancer	0.000118	0.000185	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—HRAS—thyroid cancer	0.000117	0.000183	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—SST—thyroid cancer	0.000116	0.000182	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CALCA—thyroid cancer	0.000112	0.000175	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—TP53—thyroid cancer	0.000109	0.000171	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—AKT1—thyroid cancer	0.000109	0.000171	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—TPR—thyroid cancer	0.000108	0.000169	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—SST—thyroid cancer	0.000108	0.000169	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PRKAR1A—thyroid cancer	0.000106	0.000166	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—HRAS—thyroid cancer	0.000104	0.000164	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—RXRA—thyroid cancer	0.000104	0.000163	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CALCA—thyroid cancer	0.000104	0.000163	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—AKT1—thyroid cancer	0.000103	0.000162	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CDK1—thyroid cancer	0.000101	0.000158	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—NRG1—thyroid cancer	0.0001	0.000157	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—NRAS—thyroid cancer	9.94e-05	0.000156	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—PPARG—thyroid cancer	9.85e-05	0.000154	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—NRG1—thyroid cancer	9.81e-05	0.000154	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CDK1—thyroid cancer	9.39e-05	0.000147	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—AKT1—thyroid cancer	9.22e-05	0.000145	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TERT—thyroid cancer	9e-05	0.000141	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TERT—thyroid cancer	8.81e-05	0.000138	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—HIF1A—thyroid cancer	8.61e-05	0.000135	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—KRAS—thyroid cancer	8.55e-05	0.000134	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—HIF1A—thyroid cancer	8.42e-05	0.000132	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—NRG1—thyroid cancer	8.11e-05	0.000127	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—SLC5A5—thyroid cancer	8.09e-05	0.000127	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—PTGS2—thyroid cancer	7.75e-05	0.000121	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—TP53—thyroid cancer	7.6e-05	0.000119	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—NRAS—thyroid cancer	7.59e-05	0.000119	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—NRG1—thyroid cancer	7.54e-05	0.000118	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—NRAS—thyroid cancer	7.42e-05	0.000116	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TERT—thyroid cancer	7.28e-05	0.000114	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—HRAS—thyroid cancer	7.27e-05	0.000114	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—BRAF—thyroid cancer	7.13e-05	0.000112	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—BRAF—thyroid cancer	6.97e-05	0.000109	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—HIF1A—thyroid cancer	6.97e-05	0.000109	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—RXRA—thyroid cancer	6.79e-05	0.000106	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TERT—thyroid cancer	6.77e-05	0.000106	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—PTEN—thyroid cancer	6.76e-05	0.000106	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PPARG—thyroid cancer	6.58e-05	0.000103	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—KRAS—thyroid cancer	6.53e-05	0.000102	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—HIF1A—thyroid cancer	6.47e-05	0.000101	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—AKT1—thyroid cancer	6.42e-05	0.000101	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—KRAS—thyroid cancer	6.39e-05	0.0001	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—NRAS—thyroid cancer	6.14e-05	9.62e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—BRAF—thyroid cancer	5.77e-05	9.04e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—NRAS—thyroid cancer	5.7e-05	8.94e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—HRAS—thyroid cancer	5.55e-05	8.7e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—HRAS—thyroid cancer	5.43e-05	8.51e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—AKT1—thyroid cancer	5.4e-05	8.45e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—BRAF—thyroid cancer	5.36e-05	8.4e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—KRAS—thyroid cancer	5.28e-05	8.28e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—AKT1—thyroid cancer	5.28e-05	8.27e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CCND1—thyroid cancer	5.2e-05	8.15e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PTGS2—thyroid cancer	5.18e-05	8.11e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CCND1—thyroid cancer	5.09e-05	7.98e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—PTEN—thyroid cancer	5.02e-05	7.87e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—PTEN—thyroid cancer	4.91e-05	7.7e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—KRAS—thyroid cancer	4.91e-05	7.69e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—AKT1—thyroid cancer	4.9e-05	7.68e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—AKT1—thyroid cancer	4.79e-05	7.51e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PTEN—thyroid cancer	4.52e-05	7.08e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—HRAS—thyroid cancer	4.49e-05	7.04e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—NRAS—thyroid cancer	4.48e-05	7.02e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—NRAS—thyroid cancer	4.38e-05	6.87e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—AKT1—thyroid cancer	4.37e-05	6.84e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PPARG—thyroid cancer	4.29e-05	6.72e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CCND1—thyroid cancer	4.21e-05	6.6e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—HRAS—thyroid cancer	4.17e-05	6.54e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PTEN—thyroid cancer	4.06e-05	6.37e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—AKT1—thyroid cancer	4.06e-05	6.36e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—AKT1—thyroid cancer	3.96e-05	6.21e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CCND1—thyroid cancer	3.91e-05	6.13e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—AKT1—thyroid cancer	3.9e-05	6.1e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—KRAS—thyroid cancer	3.86e-05	6.04e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PTEN—thyroid cancer	3.78e-05	5.92e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—KRAS—thyroid cancer	3.77e-05	5.91e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—AKT1—thyroid cancer	3.68e-05	5.77e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—NRAS—thyroid cancer	3.63e-05	5.68e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TP53—thyroid cancer	3.43e-05	5.37e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PTGS2—thyroid cancer	3.37e-05	5.29e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—NRAS—thyroid cancer	3.37e-05	5.28e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TP53—thyroid cancer	3.35e-05	5.25e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—HRAS—thyroid cancer	3.28e-05	5.14e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—HRAS—thyroid cancer	3.21e-05	5.02e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—KRAS—thyroid cancer	3.12e-05	4.89e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PTEN—thyroid cancer	2.94e-05	4.61e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—KRAS—thyroid cancer	2.9e-05	4.54e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—AKT1—thyroid cancer	2.89e-05	4.54e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—AKT1—thyroid cancer	2.83e-05	4.44e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TP53—thyroid cancer	2.77e-05	4.35e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—HRAS—thyroid cancer	2.65e-05	4.16e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—AKT1—thyroid cancer	2.6e-05	4.08e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TP53—thyroid cancer	2.58e-05	4.04e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—HRAS—thyroid cancer	2.46e-05	3.86e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—AKT1—thyroid cancer	2.34e-05	3.67e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—AKT1—thyroid cancer	2.18e-05	3.41e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—AKT1—thyroid cancer	1.7e-05	2.66e-05	CbGpPWpGaD
